heart failure, ventricular tachycardia, ventricular fibrillation heart failure, ventricular tachycardia, ventricular fibrillation
Conditions
Interventions
None listed
Sponsors
Inden Yasuya
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients Eligible for Implantable Cardioverter-Defibrillator (ICD) or Cardiac Resynchronization Therapy-Defibrillator (CRT-D) Based on the Joint Guidelines of the Japanese Circulation Society and the Japanese Heart Rhythm Society. 2. Patients who have had a BIOTRONIK ICD or CRT-D with HI capability implanted on or after March 19, 2019, and are already using it with home monitoring, or those who are scheduled for implantation and can use home monitoring. 3. Patients who, due to clinical necessity, have the HI function set to ON, have provided consent to participate in this study, and are able to undergo standard follow-up for one year.
Exclusion criteria
Exclusion criteria: 1. Patients who cannot use the HI score 2. Patients who cannot attend regular follow-up visits 3. Patients who do not understand the purpose of the study 4. Patients under 18 years old or those under guardianship
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity and specificity of Heart Insight for heart failure exacerbation | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Occurrence of ventricular arrhythmias 2. Consistency of arrhythmia detection by ICD and CRT-D 3. Number of days from HI alert to therapeutic intervention | — |
Contacts
Public ContactMasafumi Shimojo
Nagoya University Graduate School of Medicine
Outcome results
None listed